Paradigm Clinical Research Names Industry Veteran Kurt Mussina as CEO as Expansion Plans Are Set in Motion

Paradigm Clinical Research Names Industry Veteran Kurt Mussina as CEO as Expansion Plans Are Set in Motion

September 27, 2022

CRO Alliance Pharma’s Executive Team Grows by Four, Supporting Bioanalytical and CMC Testing Expansions

CRO Alliance Pharma’s Executive Team Grows by Four, Supporting Bioanalytical and CMC Testing Expansions

September 21, 2022

Dr. Vince Clinical Research Opens Industry-Leading Clinical Pharmacology Unit

Dr. Vince Clinical Research Opens Industry-Leading Clinical Pharmacology Unit

September 20, 2022

Veranex Expands European MedTech Capabilities With Acquisition of Medidee

Veranex Expands European MedTech Capabilities With Acquisition of Medidee

September 20, 2022

Experic Appoints Derek Hennecke to Its Board of Directors

Experic Appoints Derek Hennecke to Its Board of Directors

September 20, 2022

Elligo’s Rebecca Kush, Ph.D., Elected Chair of Vulcan Advisory Council

Elligo’s Rebecca Kush, Ph.D., Elected Chair of Vulcan Advisory Council

September 13, 2022

WCG IRB Expands Phase I Review Services, Partners With Dr. Vince Clinical Research

WCG IRB Expands Phase I Review Services, Partners With Dr. Vince Clinical Research

September 13, 2022

U.S. Alliance Pharma Expands Early Phase Bioanalytical Services Into Australia

U.S. Alliance Pharma Expands Early Phase Bioanalytical Services Into Australia

August 11, 2022

Naprotek, a Portfolio Company of Edgewater Capital Partners, Acquires MicroFab

Naprotek, a Portfolio Company of Edgewater Capital Partners, Acquires MicroFab

August 9, 2022

<strong>Dr. Vince Clinical Research Hires Two Industry Veterans, </strong><strong>Bringing Over 50 Years’ Combined Research Experience</strong>

Dr. Vince Clinical Research Hires Two Industry Veterans, Bringing Over 50 Years’ Combined Research Experience

July 26, 2022